Avista Capital Partners Iii Gp, L.p. - Net Worth and Insider Trading
Avista Capital Partners Iii Gp, L.p. Net Worth
The estimated net worth of Avista Capital Partners Iii Gp, L.p. is at least $103 dollars as of 2024-09-20. Avista Capital Partners Iii Gp, L.p. is the 10% Owner of RVL Pharmaceuticals PLC and owns about 1,032,995 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $103. Details can be seen in Avista Capital Partners Iii Gp, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Avista Capital Partners Iii Gp, L.p. has not made any transactions after 2020-01-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Avista Capital Partners Iii Gp, L.p.
Avista Capital Partners Iii Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avista Capital Partners Iii Gp, L.p. owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .
Insider Ownership Summary of Avista Capital Partners Iii Gp, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVLPQ | RVL Pharmaceuticals PLC | 2020-01-13 | 10 percent owner |
Avista Capital Partners Iii Gp, L.p. Latest Holdings Summary
Avista Capital Partners Iii Gp, L.p. currently owns a total of 1 stock. Avista Capital Partners Iii Gp, L.p. owns 1,032,995 shares of RVL Pharmaceuticals PLC (RVLPQ) as of January 13, 2020, with a value of $103.
Latest Holdings of Avista Capital Partners Iii Gp, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVLPQ | RVL Pharmaceuticals PLC | 2020-01-13 | 1,032,995 | 0.00 | 103 |
Holding Weightings of Avista Capital Partners Iii Gp, L.p.
Avista Capital Partners Iii Gp, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Avista Capital Partners Iii Gp, L.p. has made a total of 1 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RVL Pharmaceuticals PLC is the acquisition of 1,250,000 shares on January 13, 2020, which cost Avista Capital Partners Iii Gp, L.p. around $6 Million.
Insider Trading History of Avista Capital Partners Iii Gp, L.p.
- 1
Avista Capital Partners Iii Gp, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Avista Capital Partners Iii Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avista Capital Partners Iii Gp, L.p. is -23%. GuruFocus also compares Avista Capital Partners Iii Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Avista Capital Partners Iii Gp, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Avista Capital Partners Iii Gp, L.p.'s insider trading performs compared to the benchmark.
Performance of Avista Capital Partners Iii Gp, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.8 | | | | | |
| Relative Return to S&P 500(%) | 0.19 | | | | | |
Avista Capital Partners Iii Gp, L.p. Ownership Network
Avista Capital Partners Iii Gp, L.p. Owned Company Details
What does RVL Pharmaceuticals PLC do?
Who are the key executives at RVL Pharmaceuticals PLC?
Avista Capital Partners Iii Gp, L.p. is the 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and 10 percent owner Athyrium Opportunities Associates Iv Co-invest Llc .
RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary
Over the past 18 months, Avista Capital Partners Iii Gp, L.p. made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Altchem Ltd , and a net sale of 17,544,196 shares made by Foundation Harsaul .
In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.
RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
RVL Pharmaceuticals PLC Insider Transactions
Avista Capital Partners Iii Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Avista Capital Partners Iii Gp, L.p.. You might contact Avista Capital Partners Iii Gp, L.p. via mailing address: C/o Avista Capital Partners, 65 East 55t, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
